J., rskov, C., Vagn Nielsen, O
Serious risks, including kidney strain, liver issues, allergic reactions, and rare cases of Stevens-Johnson syndrome, are linked to high doses, counterfeit vials, and unsupervised administration
Practitioner-reported injectable protocols commonly recommend subcutaneous doses of 250-500 mcg daily in a fasted state, whereas published human studies have evaluated oral doses between 1 and 5 mg daily
large thiamine doses can cause severe allergic reactions
However, direct evidence linking B
Stroke recovery (the primary outcome) was monitored by behavioural tests (see ESM Methods: Assessment of stroke recovery): (1) a grip strength test, starting at 3 days after tMCAO, and weekly for 4 weeks, and (2) a corridor test, performed at weeks 1 and 4 after tMCAO (Fig